PMC:7358770 / 342-529 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":149,"end":164},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82746"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":149,"end":164},"obj":"Chemical"},{"id":"43","span":{"begin":139,"end":147},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D011134"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":12,"end":16},"obj":"Disease"},{"id":"T4","span":{"begin":139,"end":147},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":106,"end":111},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":48,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T9","span":{"begin":12,"end":16},"obj":"SP_10"},{"id":"T10","span":{"begin":34,"end":38},"obj":"SP_9"},{"id":"T11","span":{"begin":106,"end":111},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T12","span":{"begin":139,"end":147},"obj":"SP_7"},{"id":"T13","span":{"begin":149,"end":164},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T59577","span":{"begin":12,"end":16},"obj":"SP_10"},{"id":"T52242","span":{"begin":34,"end":38},"obj":"SP_9"},{"id":"T80305","span":{"begin":106,"end":111},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T43025","span":{"begin":139,"end":147},"obj":"SP_7"},{"id":"T59109","span":{"begin":149,"end":164},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T49850","span":{"begin":37,"end":41},"obj":"PG_18;PG_1"},{"id":"T82654","span":{"begin":42,"end":54},"obj":"PG_18;PG_1;CHEBI:17089;BV_11;CHEBI:17089"},{"id":"T96762","span":{"begin":56,"end":65},"obj":"PG_1"},{"id":"T93513","span":{"begin":109,"end":120},"obj":"NCBITaxon:11118"},{"id":"T62589","span":{"begin":136,"end":141},"obj":"UBERON:0002405;GO:0006955"},{"id":"T31495","span":{"begin":142,"end":151},"obj":"GO:0006955"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}

{"project":"MyTest","denotations":[{"id":"33","span":{"begin":149,"end":164},"obj":"Chemical"},{"id":"43","span":{"begin":139,"end":147},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D011134"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":", following SARS in 2002–2003 and MERS in 2012. So far, there are almost no specific clinically effective drugs and vaccines available for COVID-19. Polysaccharides with good safety, immu"}